What FDA device classes mean
FDA device classes are the starting point for most U.S. medical device regulatory plans. The FDA places medical devices into Class I, Class II or Class III based mainly on risk and on the regulatory controls needed to provide reasonable assurance of safety and effectiveness. In general, Class I devices have the lowest risk and are subject to general controls. Class II devices require general controls plus special controls. Class III devices usually require premarket approval because general and special controls alone are not considered sufficient. The class affects whether a device may be exempt, whether a 510(k) is typically required, whether De Novo classification may be relevant, or whether a PMA is expected.
For manufacturers, importers and regulatory teams, classification is more than a label. It influences development timelines, testing strategy, labeling, quality system expectations, submission planning and postmarket obligations. More regulatory topics are available in the Regulatory section.
FDA device classes at a glance
The FDA classification system is risk-based, but classification is not decided by risk alone. The agency also considers intended use, indications for use, the type of device, available evidence, risks to patients or users, and whether existing regulatory controls can address those risks.
| FDA device class | Basic meaning | Typical regulatory controls | Common premarket implication |
|---|---|---|---|
| Class I | Lowest-risk device category | General controls | Many, but not all, are exempt from 510(k) |
| Class II | Moderate-risk device category | General controls plus special controls | Many require 510(k), unless exempt |
| Class III | Highest-risk category or devices needing the most stringent review | General controls plus premarket approval requirements | Usually PMA, unless a specific exception applies |
This table is a planning summary, not a substitute for checking the device’s product code, classification regulation and applicable exemptions. Two devices that look similar from an engineering perspective can be regulated differently if they have different intended uses or indications for use.
How the FDA determines a device class
The most important classification inputs are the device’s intended use and indications for use. Intended use describes the general purpose of the device. Indications for use describe the disease, condition, population, anatomical site or clinical situation in which the device is intended to be used. A change in indications can change the risk profile and may affect classification or submission strategy.
Intended use and indications for use
Regulatory teams should define intended use and indications before relying on a product code search. For example, a cutting instrument used for general tissue work and a similar instrument labeled for a specialized ophthalmic use may raise different regulatory questions. The wording in labeling, promotional claims, instructions for use and sales discussions can all matter because classification is tied to how the device is represented for use.
Product code, regulation number and medical specialty panel
FDA classification information is typically organized by product code, regulation number and medical specialty panel. The FDA has classified roughly 1,700 generic device types across multiple medical specialty panels. A product code can point to a classification regulation, device class, review panel, submission type and exemption status. Even so, a product code match should be treated as a regulatory hypothesis until the intended use, technology characteristics and risk profile have been confirmed.
When classification is uncertain
When a device does not clearly fit an existing classification regulation or product code, the regulatory pathway may require deeper analysis. Some devices are unclassified. Some novel devices may be automatically placed into Class III unless they are reclassified through an appropriate process, such as De Novo classification for certain low- to moderate-risk devices without a legally marketed predicate. If a company needs FDA’s formal view on classification or applicable requirements, a 513(g) request may be considered.
Class I devices and general controls
Class I devices are generally the lowest-risk medical devices. General controls are the baseline FDA authorities and requirements that apply to medical devices unless a specific exemption applies. These controls may include establishment registration, device listing, labeling requirements, medical device reporting, correction and removal reporting, records, prohibitions against adulteration or misbranding, and quality management requirements.
A common misunderstanding is that Class I means “unregulated.” That is not correct. Many Class I devices are exempt from premarket notification, but exemption from 510(k) does not automatically remove all other FDA obligations. A Class I device may still be subject to registration and listing, labeling rules, complaint handling, reporting duties and the Quality Management System Regulation unless a regulation provides an exception or exemption.
Class I status also does not allow a device to make any claim the manufacturer prefers. The device must remain within the intended use and indications covered by the applicable classification. Expanding claims into a higher-risk clinical use can trigger new regulatory questions, even if the physical product has changed very little.
Class II devices and special controls
Class II devices are generally moderate-risk devices for which general controls alone are not sufficient, but for which enough information exists to establish special controls. Depending on the device type, special controls can include performance standards, postmarket surveillance, patient registries, special labeling requirements, guidance recommendations, design or performance testing, biocompatibility expectations, sterility information, electromagnetic compatibility testing, cybersecurity documentation or clinical data.
Many Class II devices enter the U.S. market through the 510(k) pathway, where the sponsor must show substantial equivalence to a legally marketed predicate device. However, not every Class II device requires a 510(k). Some Class II devices are exempt from premarket notification, subject to the limitations of the relevant exemption. The key question is not simply “Is this Class II?” but “Is this specific product code and intended use exempt or non-exempt?”
For planning purposes, Class II often requires careful comparison work. A company may need to identify a predicate, compare technological characteristics, assess differences in risk, and prepare testing that supports substantial equivalence. If no suitable predicate exists and the device is low to moderate risk, the De Novo pathway may be more appropriate than forcing a weak 510(k) strategy.
Class III devices and premarket approval
Class III devices generally present the highest level of regulatory concern. They may be life-supporting, life-sustaining, implanted, of substantial importance in preventing impairment of human health, or may present a potential unreasonable risk of illness or injury. For these devices, general and special controls are usually not enough to provide reasonable assurance of safety and effectiveness.
The typical route for a Class III device is premarket approval, commonly known as PMA. A PMA is more demanding than a 510(k) because it requires valid scientific evidence supporting the device’s safety and effectiveness for its intended use. Depending on the device, this may include clinical data, nonclinical performance testing, manufacturing information, labeling, risk analysis and information supporting the quality system.
There are important nuances. Some older preamendments Class III devices historically used 510(k) until FDA called for PMAs for that device type. Some devices may be reclassified when evidence shows that a lower level of control can provide reasonable assurance of safety and effectiveness. For a new product, companies should avoid assuming that “Class III” and “510(k)” can coexist unless the specific device type and regulatory history support that conclusion. See also: Implants.
Classification is not the same as clearance, approval or recall class
Three terms are often confused: device class, marketing authorization and recall class. They are related to FDA regulation but serve different purposes.
- Device class means Class I, Class II or Class III classification based on risk and the controls needed for safety and effectiveness.
- Marketing authorization refers to the route that permits marketing, such as 510(k) clearance, De Novo classification, PMA approval, humanitarian device exemption or an applicable exemption.
- Recall class is a separate FDA hazard classification used for recalls and corrections, also labeled Class I, Class II or Class III, but it describes the health risk of a recall situation rather than the device’s original regulatory class.
For example, a Class II medical device can be involved in a Class I recall if the recall situation presents a serious health hazard. Because the numbering system overlaps, regulatory documents should specify whether they mean device classification or recall classification.
A practical workflow for determining FDA device class
A structured classification workflow helps prevent early mistakes that can delay submissions or create avoidable redesign work. The following sequence is commonly useful for regulatory planning:
- Define the device clearly. Describe the technology, components, accessories, software functions, energy source, patient contact, duration of contact and operating environment.
- Write the intended use and indications for use. Keep the wording specific enough to support classification analysis but not broader than the evidence can support.
- Search by product type and clinical function. Look for possible product codes, classification regulations and medical specialty panels that match the intended use.
- Check the device class and exemption status. Confirm whether the device is Class I, II or III and whether any 510(k) exemption applies to the specific product code and indications.
- Review limitations of exemption. Exempt devices can lose exemption if they exceed the limits of the regulation, introduce new intended uses or raise different safety and effectiveness questions.
- Identify likely controls and evidence needs. Map general controls, special controls, recognized standards, performance testing, software documentation, cybersecurity, biocompatibility, sterility and clinical evidence expectations.
- Confirm the pathway. Decide whether the likely route is exempt, 510(k), De Novo, PMA or another pathway, and document the rationale.
This workflow also supports internal alignment. Engineering, quality, clinical, labeling and commercial teams should work from the same classification assumptions. A regulatory strategy based on one intended use can break down if marketing materials or design inputs drift toward a different claim.
2026 compliance context for device classification
Device classification continues to interact with broader FDA compliance obligations. A key current context is the FDA’s Quality Management System Regulation, which became effective on February 2, 2026. The QMSR amends 21 CFR Part 820 and incorporates ISO 13485:2016 by reference as part of FDA’s effort to harmonize and modernize medical device quality management requirements.
This update does not change the basic three-class structure, but it affects how finished device manufacturers think about quality system compliance across device classes. Class I, Class II and Class III devices may all be subject to quality management requirements unless an exception or exemption applies. Higher-risk devices often carry more demanding design, documentation, validation and submission expectations, but lower-risk classification should not be mistaken for the absence of a quality system obligation.
Another 2026 detail is that FDA has continued to update exemption-related materials and guidance. Regulatory teams should verify classification and exemption status close to the time of submission or launch, rather than relying on an old internal memo. Product code records, exemption limitations and guidance documents can change over time.
Common mistakes in FDA device class planning
Several recurring mistakes can make classification work less reliable.
- Starting with the technology instead of the intended use. FDA classification is not based only on engineering similarity. The medical purpose and claims matter.
- Assuming Class I always means no submission. Many Class I devices are exempt, but the exemption must be confirmed and other FDA controls may still apply.
- Assuming Class II always means 510(k). Many Class II devices do require 510(k), but some are exempt and some novel devices may need De Novo classification.
- Using a predicate before confirming the product code. A predicate strategy should match intended use, technological characteristics and risk questions, not just surface-level product similarity.
- Confusing FDA device class with EU device class. U.S. FDA classes and EU MDR classes use different rules and should not be mapped mechanically.
- Ignoring accessories and software functions. Accessories or software functions may have their own classification considerations, especially when they introduce independent risks or claims.
The best classification analysis is usually documented, cross-functional and revisited when claims, design, materials, software, patient population or clinical use change.
Frequently asked questions
How many FDA device classes are there?
There are three FDA device classes: Class I, Class II and Class III. Class I generally has the lowest regulatory risk profile, Class II requires special controls in addition to general controls, and Class III is generally subject to the most stringent premarket requirements.
Does every Class II device need a 510(k)?
No. Many Class II devices require a 510(k), but some are exempt from premarket notification. The exemption must be checked for the exact product code, regulation and intended use, including any limitations on the exemption.
Is a Class I device always exempt from FDA requirements?
No. A Class I device may be exempt from 510(k), but it can still be subject to other FDA requirements, including registration and listing, labeling, reporting and quality management obligations unless a specific exemption applies.
What is the difference between 510(k), De Novo and PMA?
A 510(k) generally shows substantial equivalence to a legally marketed predicate device. De Novo classification is used for certain novel low- to moderate-risk devices without a suitable predicate. PMA is generally required for Class III devices and requires valid scientific evidence supporting safety and effectiveness.
Can an FDA device class change?
Yes. A device type can be reclassified when the available evidence and regulatory analysis support a different level of control. A company’s own device may also face a different regulatory pathway if its intended use, indications, technology or risk profile changes.